THE CHEMICAL COMPOSITION OF PARABEN AND ITS EFFECTS ON HEALTH

Abstract

Parabens are a group of alkyl esters of p-hydroxybenzoic acid and usually include methyl paraben, ethyl paraben, propyl paraben, butyl paraben, isobutyl paraben, isopropyl paraben and benzyl paraben. Parabens (or their salts) are widely used as preservatives in cosmetics and medicine due to their relatively low toxicity and long history of safe use. Testing of parabens has shown, to varying degrees, that individual paraben compounds have weak estrogenic activity in some in vitro screening tests, such as estrogen receptor ligand binding, regulation of CAT gene expression, and proliferation of MCF-7 cells. Reported in vivo effects include uterine weight gain (eg, butyl, isobutyl, and benzyl parabens) and male reproductive tract effects (eg, butyl and propyl parabens). However, in relation to estrogen as a control during in vivo studies, parabens are much less active than estrogen. While exposure to sufficient doses of exogenous estrogens can increase the risk of certain adverse effects, it is hypothesized that similar risks may arise from exposure to much weaker endocrine-active chemicals (EACs) is still speculation. In evaluating the possibility that exposure to weakly active EACs may be associated with adverse effects due to their endocrine mode of action, it is important to consider both the dose and potency of these compounds compared to estrogen. In this review, a comparative approach involving dose and potency is used to assess whether in utero or adult exposure to parabens may be associated with adverse effects due to their estrogen-modulating mode of action. Keywords: parabens, p-Hydroxybenzoates, PHBA, paraben applications, Methyl paraben.